These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 13838637)

  • 1. [Can drug consumption in general be reduced and can drug costs for insurance carriers be reduced?].
    TOELKE S
    Pharm Prax; 1959; 10():149-53. PubMed ID: 13838637
    [No Abstract]   [Full Text] [Related]  

  • 2. Insurance against drug costs--a progress report.
    WILKINSON WA
    Am J Public Health Nations Health; 1960 May; 50(5):670-4. PubMed ID: 13844765
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimbursable drug classes and ceilings in Italy: why not only one?
    Garattini L; Curto A; Padula A
    Eur J Health Econ; 2016 Nov; 17(8):923-926. PubMed ID: 27255742
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug manufacturer on the savings package of Ulla Schmidt. "Grip in the moth box of planned economics"].
    Schmidt K
    MMW Fortschr Med; 2001 Nov; 143(44):52. PubMed ID: 11732398
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs.
    Robertson J; Lang D; Hill S
    J Clin Pharm Ther; 2003 Feb; 28(1):73-9. PubMed ID: 12605622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grounding Value-Based Drug Pricing in Population Health.
    Kaltenboeck A; Calsyn M; Frederix GWJ; Lowenthal J; Mitchell D; Rector B; Sarpatwari A
    Clin Pharmacol Ther; 2020 Jun; 107(6):1290-1292. PubMed ID: 31953850
    [No Abstract]   [Full Text] [Related]  

  • 7. [For the first time a health insurance company publishes drug data. Surprise: the thriftiest colleagues are in the East].
    Schmidt K
    MMW Fortschr Med; 2001 Nov; 143(44):53. PubMed ID: 11732399
    [No Abstract]   [Full Text] [Related]  

  • 8. [Informal conversation with colleagues about drugs, prices, as well as common duties and obligations].
    Hankiss J
    Orv Hetil; 1993 Oct; 134(43):2397. PubMed ID: 8233458
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical price regulation and its impact on drug innovation: mitigating the trade-offs.
    Kakkar AK
    Expert Opin Ther Pat; 2021 Mar; 31(3):189-192. PubMed ID: 33435784
    [No Abstract]   [Full Text] [Related]  

  • 10. Business of Health. International Healthcare.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-36. PubMed ID: 30681305
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription drugs: the facts about Canada.
    Consum Rep; 2005 Oct; 70(10):50-1. PubMed ID: 16163821
    [No Abstract]   [Full Text] [Related]  

  • 12. Payers struggle to ensure high level of adherence to costly specialty drugs.